CNS Pharmaceuticals, Inc.
CNSP
$1.12
-$0.005-0.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.18M | -5.61M | -2.53M | -3.54M | -5.38M |
| Total Depreciation and Amortization | 1.00K | 800.00 | 800.00 | 800.00 | 1.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 129.90K | 868.10K | 234.30K | 202.70K | 232.40K |
| Change in Net Operating Assets | -2.43M | -2.06M | 645.30K | 149.10K | 2.61M |
| Cash from Operations | -5.47M | -6.80M | -1.65M | -3.19M | -2.54M |
| Capital Expenditure | -4.20K | -- | -- | -- | -2.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.20K | -- | -- | -- | -2.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -31.20K | -92.10K | -89.90K | -87.70K | -70.70K |
| Issuance of Common Stock | 5.00M | 12.41M | 2.43M | 3.55M | 2.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.00K | -40.00K | -16.80K | -- | -202.90K |
| Cash from Financing | 4.96M | 12.28M | 2.33M | 3.46M | 2.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -511.70K | 5.48M | 676.30K | 266.50K | -360.80K |